Literature DB >> 29799627

Histological effects and pharmacokinetics of lipopolysaccharide derived from Porphyromonas gingivalis on rat maxilla and liver concerning with progression into non-alcoholic steatohepatitis.

Miyako Fujita1, Ryutaro Kuraji1,2, Hiroshi Ito1, Shuichi Hashimoto3, Toshiyuki Toen4, Tetsuya Fukada4, Yukihiro Numabe1.   

Abstract

BACKGROUND: Non-alcoholic steatohepatitis (NASH) is one of the chronic liver diseases that can develop into hepatocirrhosis. The purpose of the present study was to investigate the impact of lipopolysaccharide (LPS) from Porphyromonas gingivalis (P. gingivalis) on NASH onset, and to determine the biodistribution of double-radiolabeled LPS (R-LPS) biosynthesized in P. gingivalis.
METHODS: Rats fed a basal diet (BD) or a high-fat diet (HD) were injected with P. gingivalis-LPS or R-LPS into the palatine gingiva around the right maxillary first molar, and were classified into the following 4 groups: BD/LPS (-), BD/LPS (+), HD/LPS (-), and HD/LPS (+) or 2 groups: BD/R-LPS and HD/R-LPS.
RESULTS: Inflammation in the gingiva of the LPS (+) groups progressed significantly more than the LPS (-) groups. Furthermore, in the HD/LPS (+) liver, histologic analysis confirmed the presence of NASH, characterized by large fat droplets, ballooning degeneration, and infiltration of inflammatory cells. When 3 H, 14 C-R-LPS was injected into the palatine gingiva, radioactivity in the right palatal mucosa of HD/R-LPS rats was the highest in comparison with other regions and was significantly elevated after 24 hours compared to BD/R-LPS rats. Autoradiographic analysis of the maxilla showed distributions from the palatal mucosa to the hard palate and the interdental region. Radioactivity in organs of both BD/R-LPS and HD/R-LPS rats were mostly localized to the liver even after 24 hours.
CONCLUSION: The present study suggests that the transfer of P. gingivalis-LPS from the oral cavity to the liver plays an important role in disease exacerbation of NASH. ©2018 The Authors. Journal of Periodontology Published by Wiley Periodicals, Inc. on behalf of American Academy of Periodontology.

Entities:  

Keywords:  histology; metabolic syndrome; periodontal medicine; periodontitis; pharmacology; radiology

Mesh:

Substances:

Year:  2018        PMID: 29799627     DOI: 10.1002/JPER.17-0678

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  10 in total

Review 1.  Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.

Authors:  Ryutaro Kuraji; Satoshi Sekino; Yvonne Kapila; Yukihiro Numabe
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 7.589

2.  Periodontal disease could be a potential risk factor for non-alcoholic fatty liver disease: An 11-year retrospective follow-up study.

Authors:  Hye-Sun Shin; Min-Hee Hong; Ja-Young Moon; Seon-Ju Sim
Journal:  Clin Oral Investig       Date:  2022-05-13       Impact factor: 3.606

3.  A Diet Rich in Saturated Fat and Cholesterol Aggravates the Effect of Bacterial Lipopolysaccharide on Alveolar Bone Loss in a Rabbit Model of Periodontal Disease.

Authors:  Alfonso Varela-López; Pedro Bullón; César L Ramírez-Tortosa; María D Navarro-Hortal; María Robles-Almazán; Beatriz Bullón; Mario D Cordero; Maurizio Battino; José L Quiles
Journal:  Nutrients       Date:  2020-05-14       Impact factor: 5.717

Review 4.  Relationship between NAFLD and Periodontal Disease from the View of Clinical and Basic Research, and Immunological Response.

Authors:  Masahiro Hatasa; Sumiko Yoshida; Hirokazu Takahashi; Kenichi Tanaka; Yoshihito Kubotsu; Yujin Ohsugi; Takaharu Katagiri; Takanori Iwata; Sayaka Katagiri
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

5.  Live Combined B. subtilis and E. faecium Alleviate Liver Inflammation, Improve Intestinal Barrier Function, and Modulate Gut Microbiota in Mice with Non-Alcoholic Fatty Liver Disease.

Authors:  Jie Jiang; Jie Xiong; Jianbo Ni; Congying Chen; Kezhou Wang
Journal:  Med Sci Monit       Date:  2021-09-05

Review 6.  Pathological and Therapeutic Approach to Endotoxin-Secreting Bacteria Involved in Periodontal Disease.

Authors:  Rosalia Marcano; M Ángeles Rojo; Damián Cordoba-Diaz; Manuel Garrosa
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

Review 7.  Oral Health and Liver Disease: Bidirectional Associations-A Narrative Review.

Authors:  Fredrik Åberg; Jaana Helenius-Hietala
Journal:  Dent J (Basel)       Date:  2022-01-21

Review 8.  Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis.

Authors:  Ting Wang; Taichi Ishikawa; Minoru Sasaki; Toshimi Chiba
Journal:  Front Med (Lausanne)       Date:  2022-03-02

Review 9.  Periodontitis, chronic liver diseases, and the emerging oral-gut-liver axis.

Authors:  Emmanuel Albuquerque-Souza; Sinem E Sahingur
Journal:  Periodontol 2000       Date:  2022-03-04       Impact factor: 12.239

10.  Inflammatory response of gut, spleen, and liver in mice induced by orally administered Porphyromonas gingivalis.

Authors:  Yingman Liu; Wenkai Huang; Ke Dai; Ni Liu; Jiaqi Wang; Xiaoying Lu; Jiaojiao Ma; Manman Zhang; Mengqi Xu; Xu Long; Jie Liu; Yurong Kou
Journal:  J Oral Microbiol       Date:  2022-06-16       Impact factor: 5.833

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.